Enlivex Therapeutics Ltd. Ordinary Shares
ENLV Real Time Price USDRecent trades of ENLV by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ENLV's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
ENLV Revenue by Segment or Geography
New patents grants
-
Patent Title: Combination immune therapy and cytokine control therapy for cancer treatment May. 03, 2022
-
Patent Title: Combination immune therapy and cytokine control therapy for cancer treatment Apr. 19, 2022
-
Patent Title: Combination immune therapy and cytokine control therapy for cancer treatment May. 11, 2021
-
Patent Title: Therapeutic apoptotic cell preparations, method for producing same and uses thereof Feb. 23, 2021
-
Patent Title: Therapeutic pooled blood apoptotic cell preparations and uses thereof Dec. 08, 2020
-
Patent Title: Therapeutic apoptotic cell preparations, method for producing same and uses thereof Sep. 18, 2018
-
Patent Title: Method of preparing apoptotic monocytes Feb. 14, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ENLV
Recent picks made for ENLV stock on CNBC
ETFs with the largest estimated holdings in ENLV
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $ENLV stock a Buy, Sell, or Hold?
- What is the price target for $ENLV stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ENLV stock?
- Who owns the most shares of $ENLV stock?
- What funds own $ENLV stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ENLV Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.